跳至主要内容
临床试验/NCT01145066
NCT01145066已完成2 期

Modulation of Biomarkers and Gene Expression by Botanical Oil Supplementation in Diabetic and Metabolic Syndrome Subjects.

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2009年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
80
试验地点
1
主要终点
hsCRP

研究概览

简要总结

This study will compare how well a combination of borage and echium oils will reduce inflammation compared to fish oils and placebo oil in subjects that are diabetic or have metabolic syndrome.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults, aged 21 years or more with either diabetes or metabolic syndrome. metabolic syndrome defined by NCEP/ATPIII criteria; must have 3 out of 5 of the following risk factors: 1.central obesity, men-greater than or equal to 40 inches, women-greater than or equal to 35 inches; 2.fasting blood TG greater than or equal to 150mg/dl or be taking TG lowering medications;
  • blood HDL cholesterol, men less than 40 mg/dl, women less than 50 mg/dl;
  • blood pressure greater than or equal to 130/85 or on HTN medication
  • fasting glucose greater than or equal to 100 mg/dl.
  • participants on statins or glucose lowering drugs if dosages are stable for 3 months
  • Exclusion criteria
  • children/young adults less than 21 years of age
  • currently using anti-inflammatory drugs including NSAIDS, oral/IV steroids or injection antiinflammatory drugs(for RA), aspirin greater than 100mg/day
  • taking leukotriene receptor antagonists ( montelukast), tylenol or nasal/inhaled steroids OK.
  • currently using niacin, fibrates or fish oil
  • blood pressure greater than 170/100
  • HB1Ac greater than 10%
  • TG greater than 500 mg/dl
  • myocardial infarction/vascular surgery/stroke within the past year
  • any stage II,III,IV heart failure
  • prior cholecystectomy
  • end stage renal disease
  • BMI less than 23 or greater than 45
  • pregnancy
  • alcohol use greater than 14 drinks per week
  • current self reported tobacco or illicit drug use
  • intolerance or allergy to fish oil
  • participants taking insulin on QD or BID doses, stable for 3 months

排除标准

  • 未提供

研究组 & 干预措施

borage and echium oil combination

Experimental

borage/echium oil combination containing 0.85g/day SDA and 1.7 g/day GLA

干预措施: borage/echium oil combination (Drug)

fish oil

Active Comparator

Croda 18:12 fish oil

干预措施: fish oil (Dietary Supplement)

corn oil

Placebo Comparator

干预措施: corn oil (Dietary Supplement)

结局指标

主要结局

hsCRP

时间窗: 4 weeks and 8 weeks combined

Changes in high sensitive C-reactive protein (hsCRP) were assessed and data at 4 and 8 weeks was averaged..

Fasting Insulin

时间窗: 4 weeks and 8 weeks combined

Fasting insulin data at 4 and 8 weeks was averaged.

Leptin

时间窗: 4 weeks and 8 weeks combined

Data at 4 and 8 weeks was averaged.

次要结局

  • Fasting Glucose(4 weeks and 8 weeks combined)
  • SNPs in DNA of Selected Genes(4 weeks)
  • Serum Fatty Acids(4 weeks and 8 weeks combined)
  • Hemoglobin Levels(4 weeks and 8 weeks combined)
  • Pro and Anti-inflammatory Cytokines(4 weeks and 8 weeks combined)
  • Adipose Derived Cytokines(4 weeks)
  • PBMC Gene Expression(4 weeks)
  • PBMC Leukotriene Stimulation(4 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验